309 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 7 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x RNA TS TPMi x
ABCC1ATP binding cassette subfamily C member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 1.55e-6
Liver cancer: 5.42e-5
Mixed
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
Mixed
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedkidney:16.9
liver:23.4
ACOT13Acyl-CoA thioesterase 13Predicted intracellular proteins
Cell JunctionsOvarian cancer: 2.53e-6
Expressed in all
ADAM12ADAM metallopeptidase domain 12Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membraneRenal cancer: 2.39e-14
Tissue enrichedplacenta:237.2
ADAM22ADAM metallopeptidase domain 22Predicted membrane proteins
Predicted secreted proteins
Cell JunctionsTissue enhancedcerebral cortex:47.6
ADD3Adducin 3Disease related genes
Predicted intracellular proteins
Plasma membraneExpressed in all
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhancedcerebral cortex:50.2
testis:25.4
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneRenal cancer: 1.40e-6
Thyroid cancer: 3.19e-5
Endometrial cancer: 6.00e-5
Ovarian cancer: 2.67e-4
Glioma: 6.07e-4
Tissue enhancedcerebral cortex:14.8
spleen:17.0
ALKAnaplastic lymphoma receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneTissue enhancedcerebral cortex:2.7
testis:2.0
ALPIAlkaline phosphatase, intestinalEnzymes
Predicted secreted proteins
Plasma membraneGroup enrichedduodenum:203.2
small intestine:212.1
ALPPAlkaline phosphatase, placentalCancer-related genes
Enzymes
Plasma proteins
Predicted secreted proteins
Plasma membranePancreatic cancer: 4.33e-4
Group enrichedcervix, uterine:25.5
placenta:45.5
ALPPL2Alkaline phosphatase, placental like 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Plasma membraneTissue enhancedfallopian tube:1.5
AMOTL2Angiomotin like 2Predicted intracellular proteins
Cell JunctionsEndometrial cancer: 1.94e-4
Mixed
ANK2Ankyrin 2Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Transporters
Plasma membraneRenal cancer: 2.41e-6
Tissue enhancedcerebral cortex:184.4
ANK3Ankyrin 3Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Plasma membraneRenal cancer: 8.88e-16
Expressed in all
ANKRD13AAnkyrin repeat domain 13APredicted intracellular proteins
Plasma membraneHead and neck cancer: 7.70e-6
Ovarian cancer: 6.77e-4
Expressed in all
ANPEPAlanyl aminopeptidase, membraneCD markers
Enzymes
Plasma proteins
Predicted membrane proteins
Plasma membraneGroup enrichedduodenum:2386.4
small intestine:2133.7
ANXA13Annexin A13Plasma proteins
Predicted intracellular proteins
Plasma membraneGroup enrichedduodenum:296.6
fallopian tube:92.7
gallbladder:227.6
small intestine:235.6
AP2M1Adaptor related protein complex 2 mu 1 subunitPlasma proteins
Predicted intracellular proteins
Plasma membraneRenal cancer: 7.45e-6
Liver cancer: 9.12e-4
Expressed in all
APBB1Amyloid beta precursor protein binding family B member 1Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Plasma membraneRenal cancer: 7.44e-13
Pancreatic cancer: 1.86e-5
Liver cancer: 2.44e-4
Expressed in all
APMAPAdipocyte plasma membrane associated proteinPlasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneExpressed in all
APODApolipoprotein DCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Plasma membraneThyroid cancer: 4.12e-4
Breast cancer: 5.51e-4
Stomach cancer: 6.02e-4
Tissue enrichedbreast:4620.2
AQP1Aquaporin 1 (Colton blood group)Blood group antigen proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 1.32e-8
Head and neck cancer: 6.52e-4
Expressed in all
AQP5Aquaporin 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneHead and neck cancer: 1.75e-5
Group enrichedsalivary gland:255.6
stomach:53.3
testis:176.4
ARHGAP19Rho GTPase activating protein 19Predicted intracellular proteins
Plasma membraneRenal cancer: 7.47e-5
Tissue enhancedtestis:34.2
ARHGAP28Rho GTPase activating protein 28Predicted intracellular proteins
Cell JunctionsTissue enhancedtestis:133.0
ARHGEF15Rho guanine nucleotide exchange factor 15Predicted intracellular proteins
Plasma membraneTissue enhancedadipose tissue:37.2
ASB5Ankyrin repeat and SOCS box containing 5Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneHead and neck cancer: 5.67e-4
Tissue enhancedskeletal muscle:75.7
ATP1B3ATPase Na+/K+ transporting subunit beta 3CD markers
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 6.32e-6
Renal cancer: 1.29e-5
Endometrial cancer: 5.19e-5
Expressed in all
ATP2B1ATPase plasma membrane Ca2+ transporting 1Enzymes
Plasma proteins
Predicted membrane proteins
Plasma membraneLiver cancer: 7.74e-4
Expressed in all
ATP2B4ATPase plasma membrane Ca2+ transporting 4Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 1.21e-4
Expressed in all
BACE1Beta-secretase 1Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneUrothelial cancer: 6.76e-4
Expressed in all
BASP1Brain abundant membrane attached signal protein 1Plasma proteins
Predicted intracellular proteins
Transporters
Plasma membraneRenal cancer: 5.25e-11
Head and neck cancer: 5.63e-4
Tissue enhancedcerebral cortex:419.0
epididymis:369.1
BTN2A1Butyrophilin subfamily 2 member A1Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneUrothelial cancer: 4.52e-5
Renal cancer: 5.90e-5
Expressed in all
C11orf52Chromosome 11 open reading frame 52Predicted intracellular proteins
Cell JunctionsMixed
C14orf37Chromosome 14 open reading frame 37Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneMixed
C19orf48Chromosome 19 open reading frame 48Predicted intracellular proteins
Plasma membraneLiver cancer: 8.80e-5
Expressed in all
C1orf54Chromosome 1 open reading frame 54Predicted secreted proteins
Plasma membraneRenal cancer: 2.43e-4
Expressed in all
C4orf19Chromosome 4 open reading frame 19Predicted intracellular proteins
Cell JunctionsRenal cancer: 1.49e-11
Mixed
C9orf3Chromosome 9 open reading frame 3Enzymes
Plasma proteins
Predicted intracellular proteins
Cell JunctionsRenal cancer: 6.33e-5
Expressed in all
CA14Carbonic anhydrase 14Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneTissue enhancedcerebral cortex:10.6
seminal vesicle:21.2
CADM1Cell adhesion molecule 1Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Cell JunctionsEndometrial cancer: 1.32e-4
Mixed
CALCRLCalcitonin receptor like receptorG-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membraneTissue enhancedlung:114.3
CASKIN2CASK interacting protein 2Predicted intracellular proteins
Plasma membraneRenal cancer: 4.83e-8
Pancreatic cancer: 2.47e-5
Mixed
CBWD1COBW domain containing 1Predicted intracellular proteins
Plasma membraneExpressed in all
CBWD2COBW domain containing 2Predicted intracellular proteins
Plasma membraneEndometrial cancer: 3.22e-5
Mixed
CBWD3COBW domain containing 3Predicted intracellular proteins
Plasma membraneExpressed in all
CBWD5COBW domain containing 5Predicted intracellular proteins
Plasma membraneExpressed in all
CBWD7COBW domain containing 7Predicted intracellular proteins
Plasma membraneTissue enhancedadrenal gland:4.9
Page of 7 | next »